Medications starting with

Poland
  • FRIMIG NEO

    The medicine is used in adults for the acute treatment of migraine attacks (with or without aura). It helps relieve headache and accompanying symptoms, such as nausea, vomiting, and sensitivity to light and sound.

    Dosage form: tablets, film-coated

    Active substance Dosage
    sumatriptan succinate 70 mg

    ATC code: N02CC01

    Manufacturer: Orion Corporation

  • The medicine is used in adults for the acute treatment of migraine attacks (with or without aura). It helps to eliminate headache and relieve accompanying symptoms, such as nausea, vomiting, and sensitivity to light and sound.

    Dosage form: tablets, film-coated

    Active substance Dosage
    sumatriptan succinate 140 mg

    ATC code: N02CC01

    Manufacturer: Orion Corporation

  • It is an anti-anxiety and anti-convulsant medication. It is used to treat acute and chronic anxiety states (such as tension, anxiety, irritability, or sleep problems caused by emotional factors) and as an adjunctive treatment in epilepsy.

    Dosage form: tablets

    Active substance Dosage
    clobazam 10 mg

    ATC code: N05BA09

    Manufacturer: Sanofi-Aventis AEBE

  • The medicine is used in the treatment of acute and chronic anxiety states (such as tension, anxiety, irritability, or sleep problems of emotional origin) and as an adjunctive treatment in epilepsy.

    Dosage form: tablets

    Active substance Dosage
    clobazam 10 mg

    ATC code: N05BA09

    Manufacturer: Sanofi s.r.o.

  • It is used in the treatment of acute and chronic anxiety states (such as tension, anxiety, irritability, or sleep problems) and as an adjunctive treatment in epilepsy.

    Dosage form: tablets

    Active substance Dosage
    clobazam 10 mg

    ATC code: N05BA09

    Manufacturer: sanofi-aventis, s.r.o.

  • It is used in the treatment of acute and chronic anxiety states (such as tension, anxiety, irritability, or sleep problems caused by emotional factors) and as an adjunct therapy in epilepsy.

    Dosage form: tablets

    Active substance Dosage
    clobazam 10 mg

    ATC code: N05BA09

    Manufacturer: Atnahs Pharma Netherlands B.V.

  • It is an antibiotic used to treat upper and lower respiratory tract infections (e.g., sore throat, bronchitis, pneumonia), acute otitis media, as well as skin and soft tissue infections and certain infections caused by Mycobacterium bacteria.

    Dosage form: powder for preparation of oral suspension

    Active substance Dosage
    clarithromycin 3 g

    ATC code: J01FA09

    Manufacturer: Krka, d.d., Novo mesto

  • The medicine is intended for children aged 6 months to 12 years. It is used for the treatment of, among others, upper respiratory tract infections (e.g., pharyngitis), acute otitis media, lower respiratory tract infections (bronchitis, pneumonia), as well as skin and soft tissue infections.

    Dosage form: powder for preparation of oral suspension

    Active substance Dosage
    clarithromycin 125 mg/ 5 ml

    ATC code: J01FA09

    Manufacturer: Krka, d.d., Novo mesto

  • The medicinal product is used for the treatment of, among others, tonsillitis and pharyngitis, maxillary sinusitis, otitis media, pneumonia, exacerbation of chronic bronchitis, uncomplicated skin infections, and disseminated mycobacterial infections. It is also used to combat Helicobacter pylori bacteria in individuals with gastric or duodenal ulcers.

    Dosage form: tablets, film-coated

    Active substance Dosage
    clarithromycin 250 mg

    ATC code: J01FA09

    Manufacturer: Krka, d.d., Novo mesto

  • It is an antibiotic used to treat, among other things, tonsillitis and pharyngitis, maxillary sinusitis, otitis media, pneumonia, and exacerbations of chronic bronchitis. It is also used to treat uncomplicated skin and soft tissue infections, disseminated mycobacterial infections, and to eradicate Helicobacter pylori in cases of gastric or duodenal ulcers.

    Dosage form: tablets, film-coated

    Active substance Dosage
    clarithromycin 500 mg

    ATC code: J01FA09

    Manufacturer: Krka, d.d., Novo mesto

  • It is an antibiotic used to treat upper respiratory tract infections (e.g., sore throat, sinusitis), middle ear infections, lower respiratory tract infections (e.g., bronchitis and pneumonia), as well as skin and subcutaneous tissue infections.

    Dosage form: tablets, modified release

    Active substance Dosage
    clarithromycin 500 mg

    ATC code: J01FA09

    Manufacturer: Krka, d.d., Novo mesto

  • It is an antibiotic used to treat upper respiratory tract infections (e.g., sore throat, sinusitis), middle ear infections, lower respiratory tract infections (e.g., bronchitis and pneumonia), as well as skin and subcutaneous tissue infections.

    Dosage form: tablets, prolonged release

    Active substance Dosage
    clarithromycin 500 mg

    ATC code: J01FA09

    Manufacturer: KRKA, d.d., Novo mesto

  • It is an antibiotic used to treat upper respiratory tract infections (e.g., sore throat, sinusitis), middle ear infections, lower respiratory tract infections (e.g., bronchitis and pneumonia), as well as skin and subcutaneous tissue infections.

    Dosage form: tablets, prolonged release

    Active substance Dosage
    clarithromycin 500 mg

    ATC code: J01FA09

    Manufacturer: KRKA d.d.

  • The vaccine is used to prevent the disease caused by the tick-borne encephalitis virus. It is intended for children aged 1 to 15 years.

    Dosage form: solution for injection in ampoule-syringe

    Active substance Dosage
    aluminum hydroxide hydrate 0,17 mg
    tick-borne encephalitis virus neudorfl strain 1.2 mcg

    ATC code: J07BA01

    Manufacturer: Pfizer Manufacturing Belgium NV

  • The vaccine is used to prevent the disease caused by the tick-borne encephalitis virus. It is intended for individuals aged 16 years and older.

    Dosage form: solution for injection in ampoule-syringe

    Active substance Dosage
    tick-borne encephalitis virus neudorfl strain 2.4 mcg/0.5 ml

    ATC code: J07BA01

    Manufacturer: Pfizer Manufacturing Belgium NV

  • The medicine is used to treat skin diseases infected by bacteria sensitive to fusidic acid. It contains an antibiotic that inhibits bacterial growth and a potent corticosteroid that reduces inflammation and skin itching.

    Dosage form: cream

    Active substance Dosage
    fusidic acid 20 mg/g
    betamethasone valerate 1 mg/g

    ATC code: D07CC01

    Manufacturer: Leo Laboratoires Ltd.

  • The medicine is used for the topical treatment of bacterial skin infections. It helps in conditions such as impetigo, furunculosis, folliculitis, hidradenitis, paronychia, and ecthyma.

    Dosage form: ointment

    Active substance Dosage
    sodium fusidate 20 mg/g

    ATC code: D06AX01

    Manufacturer: LEO Pharma A/S

  • It is used for the topical treatment of skin infections caused by bacteria. It helps, among other things, in cases of impetigo, furunculosis, folliculitis, hidradenitis, paronychia, and acne vulgaris.

    Dosage form: cream

    Active substance Dosage
    fusidic acid 20 mg/g

    ATC code: D06AX01

    Manufacturer: LEO Pharma A/S

  • It is used for the topical treatment of bacterial skin infections, such as impetigo, furunculosis, folliculitis, hidradenitis, paronychia, and ecthyma.

    Dosage form: ointment

    Active substance Dosage
    sodium fusidate 20 mg/g

    ATC code: D06AX01

    Manufacturer: LEO Pharma A/S

  • The medicine is used topically for the treatment of bacterial skin infections, such as impetigo, furunculosis, folliculitis, hidradenitis, paronychia, and ecthyma.

    Dosage form: ointment

    Active substance Dosage
    sodium fusidate 20 mg/g

    ATC code: D06AX01

    Manufacturer: LEO Pharma A/S

  • The medicine is used topically to treat bacterial skin infections, such as impetigo, furunculosis, folliculitis, hidradenitis, paronychia, and acne vulgaris.

    Dosage form: cream

    Active substance Dosage
    fusidic acid 20 mg/g

    ATC code: D06AX01 D06AX01

    Manufacturer: LEO Pharma A/S

  • It is intended for the topical treatment of bacterial skin infections, such as impetigo, furunculosis, folliculitis, hidradenitis, paronychia, and acne vulgaris.

    Dosage form: cream

    Active substance Dosage
    fusidic acid 20 mg/g

    ATC code: D06AX01

    Manufacturer: LEO Pharma A/S

  • The medicine is used topically to treat bacterial skin infections. It helps, among others, with impetigo, furunculosis, folliculitis, hidradenitis, paronychia, and herpes gladiatorum.

    Dosage form: ointment

    Active substance Dosage
    sodium fusidate 20 mg/g

    ATC code: D06AX01

    Manufacturer: LEO Pharma B.V.

  • It is used for the topical treatment of bacterial skin infections, such as impetigo, furunculosis, folliculitis, hidradenitis, paronychia, and acne vulgaris.

    Dosage form: cream

    Active substance Dosage
    fusidic acid 20 mg/g

    ATC code: D06AX01

    Manufacturer: LEO Pharma A/S

  • The medicine is used topically for the treatment of bacterial skin infections, such as impetigo, furunculosis, folliculitis, hidradenitis, paronychia, and ecthyma.

    Dosage form: ointment

    Active substance Dosage
    sodium fusidate 20 mg/g

    ATC code: D06AX01

    Manufacturer: LEO Pharma B.V.

  • The medicinal product is used topically for the treatment of bacterial skin infections, such as impetigo, furunculosis, folliculitis, hidradenitis, paronychia, and ecthyma.

    Dosage form: ointment

    Active substance Dosage
    sodium fusidate 20 mg/g

    ATC code: D06AX01

    Manufacturer: LEO Pharma B.V.

  • The medicine is used to prevent breathing disorders, such as asthma and chronic obstructive pulmonary disease (COPD). It helps maintain airway patency and reduces lung swelling and irritation.

    Dosage form: powder for inhalation, divided

    Active substance Dosage
    salmeterol xinafoate 0.0725 mg
    fluticasone propionate 0.25 mg

    ATC code: R03AK06

    Manufacturer: Cipla Europe NV G.L. Pharma GmbH S&D Pharma CZ, spol. s.r.o.

  • The medicine is used to prevent breathing disorders, such as asthma and chronic obstructive pulmonary disease (COPD).

    Dosage form: powder for inhalation, divided

    Active substance Dosage
    salmeterol xinafoate 0.0725 mg
    fluticasone propionate 0.5 mg

    ATC code: R03AK06

    Manufacturer: Cipla Europe NV G.L. Pharma GmbH S&D Pharma CZ, spol. s.r.o.

  • The medicinal product is used for the initial symptomatic treatment of vitamin D deficiency in adults.

    Dosage form: capsules, soft gelatin

    Active substance Dosage
    cholecalciferol 0.5 mg (20 000 IU)

    ATC code: A11CC05

    Manufacturer: S.C.Swisscaps Romania S.R.L.

  • The medicine is used to treat postmenopausal women with a certain type of breast cancer (locally advanced or metastatic) that is hormone receptor-positive. It may also be used in combination with palbociclib in women with hormone receptor-positive breast cancer (without HER2 overexpression).

    Dosage form: solution for injection in ampoule-syringe

    Active substance Dosage
    fulvestrant 250 mg/5 ml

    ATC code: L02BA03

    Manufacturer: Accord Healthcare Polska Sp. z o.o. Pharmadox Healthcare Ltd.

  • The medicine is used in postmenopausal women for the treatment of a certain type of breast cancer (locally advanced or metastatic) that has estrogen receptors. It may also be used in combination with another medicine (palbociclib) in women with a similar type of cancer, and in premenopausal women – in combination with an additional medicine.

    Dosage form: solution for injection in ampoule-syringe

    Active substance Dosage
    fulvestrant 250 mg/5 ml

    ATC code: L02BA03

    Manufacturer: Laboratorios Farmalán, S.A.

  • This medicine is used to treat postmenopausal women with locally advanced or metastatic breast cancer that is hormone receptor-positive. It may also be used in combination with palbociclib in women with hormone receptor-positive breast cancer (without HER2 overexpression).

    Dosage form: solution for injection in ampoule-syringe

    Active substance Dosage
    fulvestrant 250 mg/5 ml

    ATC code: L02BA03

    Manufacturer: APL Swift Services (Malta) Ltd. Arrow Generiques Generis Farmacêutica, S.A.

  • The medicine is used in the treatment of postmenopausal women with a certain type of breast cancer (estrogen receptor-positive) that is locally advanced or has metastasized. It may also be used in combination with palbociclib in women with hormone receptor-positive breast cancer (without overexpression of the HER2 receptor).

    Dosage form: solution for injection in ampoule-syringe

    Active substance Dosage
    fulvestrant 250 mg

    ATC code: L02BA03

    Manufacturer: EVER Pharma Jena GmbH

  • The medicine is used in postmenopausal women for the treatment of a certain type of breast cancer (locally advanced or metastatic) that is hormone receptor-positive. It may also be used in combination with palbociclib in women with hormone receptor-positive breast cancer (without HER2 overexpression).

    Dosage form: solution for injection in ampoule-syringe

    Active substance Dosage
    fulvestrant 250 mg/5 ml

    ATC code: L02BA03

    Manufacturer: Laboratorios Farmalán, S.A.

  • The medicine is used in women with a certain type of breast cancer that is estrogen receptor-positive or hormone receptor-positive, which is locally advanced or has metastasized. It may be used as a monotherapy or in combination with another medicine (palbociclib).

    Dosage form: solution for injection in ampoule-syringe

    Active substance Dosage
    fulvestrant 250 mg/5 mL

    ATC code: L02BA03

    Manufacturer: Laboratorios Farmalán, S.A.

  • The medicine is used to treat postmenopausal women with a specific type of advanced or metastatic breast cancer that is hormone receptor-positive. It may also be used in combination with another medicine (palbociclib) in women with hormone receptor-positive breast cancer (without overexpression of the HER2 receptor).

    Dosage form: solution for injection in ampoule-syringe

    Active substance Dosage
    fulvestrant 250 mg/5 ml

    ATC code: L02BA03

    Manufacturer: Laboratorios Farmalán, S.A.

  • The medicine is used in postmenopausal women for the treatment of a specific type of breast cancer (locally advanced or metastatic). It may also be used in combination with another medicine (palbociclib) in women with a similar type of breast cancer who have not yet reached menopause.

    Dosage form: solution for injection in ampoule-syringe

    Active substance Dosage
    fulvestrant 250 mg/5 ml

    ATC code: L02BA03

    Manufacturer: Laboratorios Farmalán, S.A.

  • This medicine is used to treat postmenopausal women with a certain type of breast cancer (locally advanced or metastatic) that is hormone receptor-positive. It may also be used in combination with palbociclib in women with hormone receptor-positive breast cancer (without HER2 overexpression).

    Dosage form: solution for injection in ampoule-syringe

    Active substance Dosage
    fulvestrant 250 mg

    ATC code: L02BA03

    Manufacturer: Betapharm Arzneimittel GmbH

  • The medicine is used to treat postmenopausal women with a certain type of breast cancer (locally advanced or metastatic). It may also be used in combination with palbociclib in women with a certain type of breast cancer, whereby premenopausal women must also take a medicine called an LHRH agonist.

    Dosage form: solution for injection in ampoule-syringe

    Active substance Dosage
    fulvestrant 250 mg/ 5ml

    ATC code: L02BA03

    Manufacturer: Ebewe Pharma Ges.m.b.H Nfg. KG Fareva Unterach GmbH LEK Pharmaceuticals d.d.

  • This medicine is used to treat postmenopausal women with a certain type of breast cancer (locally advanced or metastatic) that is hormone receptor-positive. It may also be used in combination with another medicine (palbociclib) in women with a similar type of breast cancer who do not have an overexpression of the HER2 receptor.

    Dosage form: solution for injection in ampoule-syringe

    Active substance Dosage
    fulvestrant 250 mg/5 ml

    ATC code: L02BA03

    Manufacturer: S.C. Rompharm Company S.R.L.

  • The medicine is used to treat breast cancer in postmenopausal women (when the tumor is locally advanced or has metastasized) or in combination with another medicine (palbociclib) in the case of hormone receptor-positive breast cancer. In premenopausal women, it is used in combination with an additional medicine.

    Dosage form: solution for injection in ampoule-syringe

    Active substance Dosage
    fulvestrant 250 mg/5 ml

    ATC code: L02BA03

    Manufacturer: Sun Pharmaceutical Industries Europe B.V.

  • The medicinal product is used in postmenopausal women to treat a certain type of advanced or metastatic breast cancer with the presence of estrogen receptors. It may also be used in combination with another medicinal product (palbociclib) in women with hormone receptor-positive breast cancer.

    Dosage form: solution for injection in ampoule-syringe

    Active substance Dosage
    fulvestrant 250 mg/ 5 ml

    ATC code: L02BA03

    Manufacturer: PLIVA Hrvatska d.o.o. (Pliva Croatia Ltd.)

  • The medicine is used in postmenopausal women for the treatment of a certain type of breast cancer (estrogen receptor-positive) that is locally advanced or has metastasized. It may also be used in combination with another medicine (palbociclib) in women with hormone receptor-positive breast cancer.

    Dosage form: solution for injection in ampoule-syringe

    Active substance Dosage
    fulvestrant 250 mg/5ml

    ATC code: L02BA03

    Manufacturer: Laboratorios Farmalán, S.A.

  • This medicine is used to treat postmenopausal women with a certain type of breast cancer (locally advanced or metastatic) that has estrogen receptors. It may also be used in combination with palbociclib in women with hormone receptor-positive breast cancer (without overexpression of the HER2 receptor).

    Dosage form: solution for injection in ampoule-syringe

    Active substance Dosage
    fulvestrant 250 mg/5 ml

    ATC code: L02BA03

    Manufacturer: Laboratorios Farmalán, S.A.

  • The medicine is used to treat relapsing-remitting multiple sclerosis (MS) in individuals over 13 years of age. It helps prevent the immune system from damaging the brain and spinal cord, which may slow the progression of the disease.

    Dosage form: capsules, hard, intestinal

    Active substance Dosage
    dimethyl fumarate 120 mg

    ATC code: L04AX07

    Manufacturer: Adamed Pharma S.A.

  • The medicine is used to treat relapsing-remitting multiple sclerosis (MS) in patients aged 13 years and older. It helps prevent the immune system from damaging the brain and spinal cord, which may slow the progression of the disease.

    Dosage form: capsules, hard, intestinal

    Active substance Dosage
    dimethyl fumarate 240 mg

    ATC code: L04AX07

    Manufacturer: Adamed Pharma S.A.

  • The medicine is used for the treatment of relapsing-remitting multiple sclerosis in patients aged 13 years and older.

    Dosage form: capsules, hard, intestinal

    Active substance Dosage
    dimethyl fumarate 240 mg

    ATC code: L04AX07

    Manufacturer: Laboratori Fundació Dau

  • Fumatyl is used to treat relapsing-remitting multiple sclerosis in patients aged 13 years and older.

    Dosage form: capsules, hard, intestinal

    Active substance Dosage
    dimethyl fumarate 120 mg

    ATC code: L04AX07

    Manufacturer: Laboratori Fundació Dau

  • The medicine is used to treat patients with severe, life-threatening fungal infections.

    Dosage form: solution for infusion, powder for preparation of

    Active substance Dosage
    amphotericin b 50 mg

    ATC code: J02AA01

    Manufacturer: CHEPLAPHARM Arzneimittel GmbH

  • The medicine is used in the case of fungal infections of the external and middle ear caused by yeasts, moulds, or other types of fungi.

    Dosage form: drops, ear solution

    Active substance Dosage
    clotrimazole 10 mg/g

    ATC code: D01AC01

    Manufacturer: Laboratórios Basi - Pharmaceutical Industry, S.A.